secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2024-06-04T23:59:59+00:00
Accession:  0001140361-24-028711
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave pays off $6.3M Celularity note for $2.075M, extends SEPA merger deadline to June 30
--------------------------------------------------------------------------------

- Paid $2.075 million to settle and extinguish a $6.3 million note and interest owed to Celularity from the 2020 UltraMist acquisition.
- Withdrew Nasdaq listing application due to bid price requirement; submitted application to Cboe BZX Exchange, currently under review.
- Extended SEPA merger outside date to June 30, 2024; Sanuwave received unilateral right to terminate the merger agreement at any time.
- Reaffirmed FY2024 revenue guidance above $30 million (50% growth) and Q2 2024 revenue growth of 45-55% versus Q2 2023.
- Capital raise from longtime shareholders funded the debt settlement; company believes it is sufficiently funded for remainder of 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124028711/0001140361-24-028711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124028711/ef20030490_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-028711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer